<!DOCTYPE html>
<html>
<head>
<title>orsum result</title>
</head>
<body>

<details>
<summary>WP5087 Malignant pleural mesothelioma</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5087 Malignant pleural mesothelioma (rank: 1, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	WP5087 Malignant pleural mesothelioma (rank: 1, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	WP5087 Malignant pleural mesothelioma (rank: 3, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	WP5087 Malignant pleural mesothelioma (rank: 1, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	WP5087 Malignant pleural mesothelioma (rank: 3, term size: 1)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4879 Overlap between signal transduction pathways contributing to LMNA laminopathies</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4879 Overlap between signal transduction pathways contributing to LMNA laminopathies (rank: 5, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	WP4879 Overlap between signal transduction pathways contributing to LMNA laminopathies (rank: 1, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4950 16p11.2 distal deletion syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	WP4950 16p11.2 distal deletion syndrome (rank: 1, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4545 Oxysterols derived from cholesterol</summary>
	<p style="margin-left:40px">
	Overlap<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	WP4545 Oxysterols derived from cholesterol (rank: 1, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP2447 Amyotrophic lateral sclerosis (ALS)</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP2447 Amyotrophic lateral sclerosis (ALS) (rank: 3, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	WP2447 Amyotrophic lateral sclerosis (ALS) (rank: 1, term size: 1)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4298 Acute viral myocarditis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4298 Acute viral myocarditis (rank: 2, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	WP4298 Acute viral myocarditis (rank: 2, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	WP4298 Acute viral myocarditis (rank: 4, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	WP4298 Acute viral myocarditis (rank: 2, term size: 1)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4844 Influence of laminopathies on Wnt signaling</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4844 Influence of laminopathies on Wnt signaling (rank: 22, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	WP4844 Influence of laminopathies on Wnt signaling (rank: 2, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4830 GDNF/RET signaling axis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4830 GDNF/RET signaling axis (rank: 10, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	WP4830 GDNF/RET signaling axis (rank: 2, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4541 Hippo-Merlin signaling dysregulation</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4541 Hippo-Merlin signaling dysregulation (rank: 13, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	WP4541 Hippo-Merlin signaling dysregulation (rank: 2, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP5053 Development of ureteric collection system</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5053 Development of ureteric collection system (rank: 4, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP2059 Alzheimer's disease and miRNA effects</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP2059 Alzheimer's disease and miRNA effects (rank: 7, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	WP2059 Alzheimer's disease and miRNA effects (rank: 4, term size: 1)<br>
	<br>
	</p>
</details>

<details>
<summary>WP4549 Fragile X syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4549 Fragile X syndrome (rank: 14, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	WP4549 Fragile X syndrome (rank: 5, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP5124 Alzheimer's disease</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5124 Alzheimer's disease (rank: 6, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	WP5124 Alzheimer's disease (rank: 5, term size: 1)<br>
	<br>
	</p>
</details>

<details>
<summary>WP3853 ERK pathway in Huntington's disease</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP3853 ERK pathway in Huntington's disease (rank: 17, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	WP3853 ERK pathway in Huntington's disease (rank: 6, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP3584 MECP2 and associated Rett syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP3584 MECP2 and associated Rett syndrome (rank: 8, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP3995 Prion disease pathway</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP3995 Prion disease pathway (rank: 9, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4746 Thyroid hormones production and peripheral downstream signaling effects</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4746 Thyroid hormones production and peripheral downstream signaling effects (rank: 11, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4823 Genes controlling nephrogenesis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4823 Genes controlling nephrogenesis (rank: 12, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4871 Kisspeptin/kisspeptin receptor system in the ovary</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4871 Kisspeptin/kisspeptin receptor system in the ovary (rank: 15, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4673 Male infertility</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4673 Male infertility (rank: 16, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP5102 Familial partial lipodystrophy (FPLD)</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5102 Familial partial lipodystrophy (FPLD) (rank: 18, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4288 MTHFR deficiency</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4288 MTHFR deficiency (rank: 19, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP5103 Progeria-associated lipodystrophy</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5103 Progeria-associated lipodystrophy (rank: 20, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP5074 Kallmann syndrome</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5074 Kallmann syndrome (rank: 21, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4540 Hippo signaling regulation pathways</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4540 Hippo signaling regulation pathways (rank: 23, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP5110 Familial hyperlipidemia type 3</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5110 Familial hyperlipidemia type 3 (rank: 24, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP4224 Purine metabolism and related disorders</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP4224 Purine metabolism and related disorders (rank: 25, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP2371 Parkinson's disease pathway</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP2371 Parkinson's disease pathway (rank: 26, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>

<details>
<summary>WP5120 Inclusion body myositis</summary>
	<p style="margin-left:40px">
	Overlap<br>
	WP5120 Inclusion body myositis (rank: 27, term size: 1)<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_2<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_3<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_4<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_6<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_7<br>
	<br>
	</p>
	<p style="margin-left:40px">
	AM_10<br>
	<br>
	</p>
</details>
</body>
</html>
